GUERIN MARK PATRICK (Chief Financial Officer) purchased 11.5% of their position (15K shares) of TRAWS PHARMA, INC. on the open market
Open‑market purchase worth $15.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/17/2021ACC: 0001179110-21-001784
Officer· Chief Financial Officer
Since Jul 2018
+15K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$1.00
Trade value
$15K
% of position
11.5%
2/16/2021
130.21K→145.21K
Total
Net shares
+15K
Net value
$15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2021 | P · Purchase | +15K | $1.00 | $15K | 11.5% | 130.21K | 145.21K |
| Total | +15K | $15K | ||||||
Derivative Transactions0
No derivative transactions reported